The authors investigated the efficacy and safety of WBRT combined with temozolomide (TMZ) in this population, to improve the therapeutic index of whole–brain radiation therapy (WBRT) in the treatment of brain metastases from breast cancer. Whole–brain radiation therapy combined with temozolomide did not significantly improve local control and survival in patients with brain metastases from breast cancer.

READ FULL ARTICLE Curated publisher From Mdlinx